Understanding the molecular biology of epilepsy is a challenge for modern science. Epilepsy results from alternations in fundamental mechanisms of brain and membrane function. Although an understanding of the mode of inheritance and the etiology of genetic epilepsy syndromes forms the basis for genetic counseling, the development of specific therapies will come from knowing the basic mechanisms of epilepsy. Defining the genes causing epilepsy requires an unambiguous definition of seizure phenotype, along with the stability of that trait, an unremitting clinical course, and an abundance of clinical material. This article reviews the task of defining the genetics of epilepsy and discusses genetic methodology, idiopathic generalized and localization-related partial epilepsies, neuronal migration disorders, progressive myoclonus epilepsies, molecular biology of epileptogenesis, and future research. (J Child Neurol 2002;17:S18—S27).
Get full access to this article
View all access options for this article.
References
1.
Watson JD, Tooze J., Kurtz DT: Recombinant DNA. A Short Course. New York, Scientific American Books, 1983.
2.
Commission on Classification and Terminology of the International League Against Epilepsy: Proposal for classification of epilepsies and epileptic syndromes. Epilepsia1985;26:268—278.
3.
Commission on Classification and Terminology of the International League Against Epilepsy: Proposal for revised clinical and electroencephalographic classification of epileptic seizures . Epilepsia1981;22:489—501.
4.
Durner M., Keddache MA, Tomasini L., et al: Genome scan of idiopathic generalized epilepsy: Evidence for major susceptibility gene and modifying genes influencing the seizure type . Ann Neurol2001;49:328—335.
Zonana J., Silvey K., Strimling B.: Familial neonatal and infantile seizures: An autosomal-dominant disorder. Am J Med Genet1984; 18:455—459.
7.
Leppert M., Anderson VE, Quattlebaum T., et al: Benign neonatal convulsions linked to genetic markers on chromosome 20. Nature1989;337:647—648.
8.
Berkovic SF, Kennerson ML, Howell RA, et al: Phenotypic expression of benign familial neonatal convulsions linked to chromosome 20. Arch Neurol1994;51:1125—1128.
9.
Lewis TB, Leach RJ, Ward K., et al: Genetic heterogeneity in benign familial neonatal convulsions: Identification of a new locus on chromosome 8q. Am J Hum Genet1993;53:670—675.
10.
Charlier C. , Singh NA, Ryan SG, et al: A pore mutation in a novel KQT-like potassium channel gene in an idiopathic epilepsy family. Nat Genet1998;18:53—55.
11.
Biervert C. , Schroeder BC, Kubisch C., et al: A potassium channel mutation in neonatal human epilepsy. Science1998;279:403—406.
12.
Singh NA, Charlier C., Stauffer D., et al: A novel potassium channel gene, KCNQ2, is mutated in inherited epilepsy of newborns. Nat Genet1998;18:25—29.
13.
Wallace RH, Wang DW, Singh R., et al: Febrile seizures and generalized epilepsy associated with a mutation in the Na+-channel beta1 subunit gene SCN1B. Nat Genet1998;19:366—370.
14.
Wang Q., Curran ME, Splawski I., et al: Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias. Nat Genet1996;12:17—23.
15.
Neyroud N., Tesson F., Denjoy I., et al: A novel mutation in the potassium channel gene KVLQT1 causes the Jervell and Lange-Nielsen cardioauditory syndrome. Nat Genet1997;15:186—189.
16.
Schroeder BC , Kubisch C., Stein V., Jentsch TJ: Moderate loss of function of cyclic-AMP-modulated KCNQ2/KCNQ3 K+ channels causes epilepsy. Nature1998;396:687—690.
17.
Molina A., Ortega-Saenz P., Lopez-Barneo J.: Pore mutations alter closing and opening kinetics in Shaker K+ channels. J Physiol (Lond) 1998;509:327—337.
18.
Dreyer I., Becker D., Bregante M., et al: Single mutations strongly alter the K+-selective pore of the K(in) channel KAT1. FEBS Lett1998;430:370—376.
19.
Guo L., Kubo Y.: Comparison of the open-close kinetics of the cloned inward rectifier K+ channel IRK1 and its point mutant (Q140E) in the pore region. Receptor Channels1998;5:273—289.
20.
Vigevano F., Cusmai R., Ricci S., Watanabe K.: Benign epilepsies of infancy, in Engel J Jr , Pedley TA (eds): Epilepsy: A Comprehensive Textbook. Philadelphia, Lippincott-Raven, 1997, 2269—2276.
21.
Watanabe K. , Yamamoto N., Negoro T., et al: Benign infantile epilepsy with complex partial seizures. J Clin Neurophysiol1990 ;7:409—416.
22.
Vigevano F. , Fusco L., Di Capula M., et al: Benign infantile familial convulsions . Eur J Pediatr1992;151:608—612.
23.
Guipponi M. , Rivier F., Vigevano F., et al: Linkage mapping of benign familial infantile convulsions (BFIC) to chromosome 19q. Hum Mol Genet1997;6:473—477.
24.
Malafosse A. , Beck C., Bellet H., et al: Benign infantile familial convulsions are not an allelic form of the benign familial neonatal convulsions gene. Ann Neurol2001;35:479—482.
25.
Dreifuss F. : Pediatric epilepsy syndromes: An overview. Cleve Clin J Med1989;56:166—171.
26.
Gastaut H., Zifkin BG, Mariani E., Puig JS: The long-term course of primary generalized epilepsy with persisting absences . Neurology1986;36:1021—1028.
27.
Wirrell EC, Camfield CS, Camfield PR, et al: Long-term prognosis of typical childhood absence epilepsy: Remission or progression to juvenile myoclonic epilepsy. Neurology1996;47:912—918.
28.
Metrakos K. , Metrakos Jde: Genetics of convulsive disorders, I: Introduction, problems, methods and baselines. Neurology1960; 10: 228—240.
29.
Metrakos K. , Metrakos Jde: Genetics of convulsive disorders, II: Genetics and electroencephalographic studies in centrencephalic epilepsy. Neurology1961;11:474—483.
30.
Berkovic SF , Howell RA, Hay DA, Hopper JL: Epilepsies in twins: Genetics of the major epilepsy syndromes. Ann Neurol1998;43: 435—445.
31.
Degen R., Degen HE, Roth C.: Some genetic aspects of idiopathic and symptomatic absence seizures: Waking and sleep EEGs in siblings. Epilepsia1990 ;31:784—794.
32.
Serratosa JM : Idiopathic epilepsies with a complex mode of inheritance. Epilepsia1999;40(Suppl 3):12—16.
33.
Fong GC, Shah PU, Gee MN, et al: Childhood absence epilepsy with tonic-clonic seizures and electroencephalogram 3-4 Hz spike and multispike-slow-wave complexes: Linkage to chromosome 8q24 . Am J Hum Genet1998;63:1117—1129.
34.
Delgado-Escueta AV, Medina MD, Serratosa JM, et al: Mapping and positional cloning of common idiopathic generalized epilepsies: Juvenile myoclonus epilepsy and childhood absence epilepsy, in Delgado-Escueta AV, Wilson WA, Olsen RW, Porter RJ (eds): Jasper's Basic Mechanisms of the Epilepsies. Philadelphia , Lippincott Williams & Wilkins, 1999, 351—374.
Roger J., Bureau M., Dravet C., et al: Epileptic Syndromes in Infancy, Childhood, and Adolescence. London, John Libbey, 1992.
37.
Wolf P., Inoue Y.: Therapeutic response of absence seizures in patients of an epilepsy clinic for adolescents and adults. J Neurol1984;231:225—229.
38.
Sander T., Hildmann T., Kretz R., et al: Allelic association of juvenile absence epilepsy with a GluR5 kainate receptor gene (GRIK1) polymorphism. Am J Med Genet1997;74:416—421.
39.
Panayiotopoulos CP, Obeid T.: Juvenile myoclonic epilepsy: An autosomal recessive disease. Ann Neurol1989;25:440—443.
40.
Tsuboi T., Christian W.: On the genetics of the primary generalized epilepsy with sporadic myoclonias of impulsive petit mal type: A clinical and electroencephalographic study of 399 probands. Humangenetik1973;19:155—182.
41.
Andermann E.: Multifactorial inheritance of generalized and focal epilepsy, in Anderson VE, Hauser WA, Penry JK, Sing CF (eds): Genetic Basis of the Epilepsies. New York , Raven Press, 1982, 355—374.
42.
Greenberg DA, Delgado-Escueta AV, Maldonaldo HM, Widelitz H.: Segregation analysis of juvenile myoclonic epilepsy, in Beck-Mannagetta G, Anderson VE, Doose H, Janz D (eds): Genetics of the Epilepsies. Berlin, Springer, 1989, 53—61.
43.
Delgado-Escueta AV, Greenberg DA, Weissbecker KA, et al: Gene mapping in the idiopathic generalized epilepsies: Juvenile myoclonic epilepsy, childhood absence epilepsy, epilepsy with grand mal seizures, and early childhood myoclonic epilepsy. Epilepsia1990;31(Suppl 3):S19—S29.
44.
Greenberg DA, Delgado-Escueta AV, Widelitz H., et al: Juvenile myoclonic epilepsy (JME) may be linked to the BF and HLA loci on human chromosome 6. Am J Med Genet1988;31:185—192.
45.
Liu AW, Delgado-Escueta AV, Serratosa JM, et al: Juvenile myoclonic epilepsy locus in chromosome 6p21.2-p11: Linkage to convulsions and electroencephalography trait. Am J Hum Genet1995;57:368—381.
46.
Weissbecker KA , Durner M., Janz D., et al: Confirmation of linkage between juvenile myoclonic epilepsy locus and the HLA region of chromosome 6. Am J Med Genet1991;38:32—36.
47.
Sander T., Bockenkamp B., Hildmann T., et al: Refined mapping of the epilepsy susceptibility locus EJM1 on chromosome 6. Neurology1997;49:842—847.
48.
Durner M., Sander T., Greenberg DA, et al: Localization of idiopathic generalized epilepsy on chromosome 6p in families of juvenile myoclonic epilepsy patients. Neurology1991;41:1651—1655.
49.
Whitehouse WP, Rees M., Curtis D., et al: Linkage analysis of idiopathic generalized epilepsy (IGE) and marker loci on chromosome 6p in families of patients with juvenile myoclonic epilepsy: No evidence for an epilepsy locus in the HLA region. Am J Hum Genet1993;53:652—662.
50.
Elmslie FV, Rees M., Williamson MP, et al: Genetic mapping of a major susceptibility locus for juvenile myoclonic epilepsy on chromosome 15q. Hum Mol Genet1997;6:1329—1334.
51.
Zara F., Bianchi A., Avanzini G., et al: Mapping of genes predisposing to idiopathic generalized epilepsy . Hum Mol Genet1995;4:1201—1207.
52.
Sander T., Kretz R., Schulz H., et al: Replication analysis of a putative susceptibility locus (EGI) for idiopathic generalized epilepsy on chromosome 8q24. Epilepsia1998;39:715—720.
53.
Plaster NM, Uyama E., Uchino M., et al: Genetic localization of the familial adult myoclonic epilepsy (FAME) gene to chromosome 8q24. Neurology1999;53:1180—1183.
54.
Phillips HA , Scheffer IE, Berkovic SF, et al: Localization of a gene for autosomal dominant nocturnal frontal lobe epilepsy to chromosome 20q13.2. Nat Genet1995;10:117—118.
55.
Steinlein OK , Mulley JC, Propping P., et al: A missense mutation in the neuronal nicotinic acetylcholine receptor alpha 4 subunit is associated with autosomal dominant nocturnal frontal lobe epilepsy. Nat Genet1995;11:201—203.
56.
Steinlein O. , Magnusson A., Stoodt J., et al: An insertion mutation of the CHRNA4 gene in a family with autosomal dominant nocturnal frontal lobe epilepsy. Hum Mol Genet1997;6:943—947.
57.
Wevers A., Jeske A., Lobron C., et al: Cellular distribution of nicotinic acetylcholine receptor subunit mRNAs in the human cerebral cortex as revealed by non-isotopic in situ hybridization . Mol Brain Res1994;25:122—128.
58.
Weiland S., Witzemann V., Villarroel A., et al: An amino acid exchange in the second transmembrane segment of a neuronal nicotinic receptor causes partial epilepsy by altering its desensitization kinetics. FEBS Lett1996;398:91—96.
59.
Kuryatov A. , Gerzanich V., Nelson M., et al: Mutation causing autosomal dominant nocturnal frontal lobe epilepsy alters Ca2+ permeability, conductance, and gating of human α4β2 nicotinic acetylcholine receptors. J Neurosci1997;17:9035—9047.
60.
Phillips HA , Scheffer IE, Crossland KM, et al: Autosomal dominant nocturnal frontal-lobe epilepsy: Genetic heterogeneity and evidence for a second locus at 15q24. Am J Hum Genet2001;63: 1108—1116.
61.
Berkovic SF , Scheffer IE: Epilepsies with single gene inheritance. Brain Dev1997;19:13—18.
62.
Scheffer IE , Bhatia KP, Lopes-Cendes I., et al: Autosomal dominant frontal lobe epilepsy misdiagnosed as sleep disorder. Lancet1994 ; 343:515—517.
63.
Scheffer IE , Bhatia KP, Lopes-Cendes I., et al: Autosomal dominant nocturnal frontal epilepsy: A distinctive clinical disorder. Brain1995;118:61—73.
64.
Steinlein O. , Smigrodzki R., Lindstrom J., et al: Refinement of the localization of the gene for neuronal nicotinic acetylcholine receptor alpha4 subunit (CHRNA4) to human chromosome 20ql 3.2-13.3. Genomics1994;22:493—495.
65.
Perucca E., Bialer M.: The clinical pharmacokinetics of the newer antiepileptic drugs. Clin Pharmacokinet1996;1:29—46.
66.
Loiseau P., Duche B., Cordova S., Dartigues J.: Prognosis of benign childhood epilepsy with centrotemporal spikes: A follow-up study of 168 patients. Epilepsia1988;29:229—235.
67.
Frost JD, Hrachovy RA, Glaze DGSpike morphology in childhood focal epilepsy: Relationship to syndromic classification . Epilepsia1992;33:531—536.
68.
Gutierrez AR , Brick JF, Bodensteiner J.: Dipole reversal: An ictal feature of benign partial epilepsy with centrotemporal spikes. Epilepsia1990;31:705—711.
69.
Bray FP, Wiser WC: Evidence for a genetic aetiology of temporal central abnormalities in focal epilepsy. N Engl J Med1964;271: 926—933.
70.
Neubauer BA , Fiedler B., Himmelein B., et al: Centrotemporal spikes in families with rolandic epilepsy: Linkage to chromosome 15q14. Neurology1998;51:1608—1612.
71.
Scheffer IE , Jones L., Pozzebon M., et al: Autosomal dominant rolandic epilepsy and speech dyspraxia: A new syndrome with anticipation. Ann Neurol1995;38:633—642.
72.
Berkovic SF , McIntosh A., Howell RA, et al: Familial temporal lobe epilepsy: A common disorder identified in twins. Ann Neurol1996;40:227—235.
73.
Ottman R., Risch N., Hauser WA, et al: Localization of a gene for partial epilepsy to chromosome 10q . Nat Genet1995;10:56—60.
74.
Winawer MR, Ottman R., Hauser WA, Pedley TA: Autosomal dominant partial epilepsy with auditory features: Defining the phenotype . Neurology2001;54:2173—2176.
75.
Michelucci R., Passarelli D., Pitzalis S., et al. Autosomal dominant partial epilepsy with auditory features: Description of a new family. Epilepsia2000;41:967—970.
76.
Scheffer IE , Phillips HA, O'Brien CE, et al: Familial partial epilepsy with variable foci: A new partial epilepsy syndrome with suggestion of linkage to chromosome 2. Ann Neurol1998;44:890—899.
77.
Verity CM, Butler NR, Golding J.: Febrile convulsions in a national cohort followed up from birth. I—Prevalence and recurrence in the first five years of life. BMJ1985;290:1307—1310.
78.
Nelson KB, Ellenberg JH: Prognosis of children with febrile seizures. Pediatrics1978;61:720—727.
79.
Macdonald BK , Johnson AL, Sander JW, Shorvon SD: Febrile convulsions in 220 children—Neurological sequelae at 12 years follow-up. Eur Neurol1999;41:179—186.
80.
Berg AT, Shinnar S., Shapiro ED, et al: Risk factors for a first febrile seizure: A matched case-control study. Epilepsia1995;36: 344—351.
81.
Nelson KB, Ellenberg JH: Prenatal and perinatal antecedents of febrile seizures. Ann Neurol1990;27:127—131.
82.
Corey LA, Berg K., Pellock JM: The occurrence of epilepsy and febrile seizures in Virginian and Norwegian twins. Neurology1991;41:1433—1436.
83.
Kugler SL, Stenroos ES, Mandelbaum DE, et al. Hereditary febrile seizures: Phenotype and evidence for a chromosome 19p locus. Am J Med Genet1998;79:354—361.
84.
Peiffer A., Thompson J., Charlier C., et al: A locus for febrile seizures (FEB3) maps to chromosome 2q23-24 . Ann Neurol1999;46:671—678.
85.
Scheffer IE, Berkovic SF: Generalized epilepsy with febrile seizures plus: A genetic disorder with heterogeneous clinical phenotypes. Brain1997;120:479—490.
86.
Baulac S., Gourfinkel-An I., Picard F., et al: A second locus for familial generalized epilepsy with febrile seizures plus maps to chromosome 2q21-q33. Am J Hum Genet1999;65:1078—1085.
87.
Lopes-Cendes I., Scheffer IE, Berkovic SF, et al: Mapping a locus for idiopathic epilepsy in a large multiplex family. Epilepsia1996 ;37:127.
88.
Makita N., Sloan-Brown K., Weghuis DO, et al: Genomic organization and chromosomal assignments of the human voltage-gated Na+ channel beta 1 subunit gene (SCN1B). Genomics1994;23:628—634.
89.
Mohrenweiser HW, Tsujimoto S., Gordon L., Olsen AS: Regions of sex-specific hypo- and hyper-recombination identified through integration of 180 genetic markers into the metric physical map of human chromosome 19. Genomics1998;47:153—162.
90.
Isom LL, De Jongh KS, Patton DE, et al: Primary structure and functional expression of the beta 1 subunit of the rat brain sodium channel. Science1992 ;256:839—842.
91.
Makita N., Bennett PB, George AL: Voltage-gated Na+ channel beta 1 subunit mRNA expressed in adult human skeletal muscle, heart, and brain is encoded by a single gene. J Biol Chem1994;269: 7571—7578.
92.
Moulard B., Guipponi M., Chaigne D., et al: Identification of a new locus for generalized epilepsy with febrile seizures plus (GEFS+) on chromosome 2q24-q33. Am J Hum Genet1999;65:1396—1400.
93.
Wallace RH, Scheffer IE, Barnett S., et al: Neuronal sodium-channel alpha1-subunit mutations in generalized epilepsy with febrile seizures plus. Am J Hum Genet2001;68:859—865.
94.
Makita N., Bennett PB, George AL: Molecular determinants of beta 1 subunit-induced gating modulation in voltage-dependent Na+ channels. J Neurosci1996;16:7117—7127.
95.
McCormick KA , Isom LL, Ragsdale D., et al: Molecular determinants of Na+ channel function in the extracellular domain of the beta 1 subunit. J Biol Chem1998;273:3954—3962.
96.
Dobyns WB, Truwit CL: Lissencephaly and other malformations of cortical development: 1995 update . Neuropediatrics1995;26: 132—147.
97.
Hattori M., Adachl H., Tsujimoto M., et al: Miller-Dieker lissencephaly gene encodes a subunit of brain platelet-activating factor. Nature1994;370:216—218.
98.
Lo Nigro C., Chong CS, Smith AC, et al: Point mutations and an intragenic deletion in LIS1, the lissencephaly causative gene in isolated lissencephaly sequence and Miller-Dieker syndrome. Hum Mol Genet1997;6:157—164.
99.
Dobyns WB, Andermann E., Andermann F., et al: X-linked malformations of neuronal migration. Neurology1996;47:331—339.
100.
des Portes V., Pinard JM, Billuart P., et al: A novel CNS gene required for neuronal migration and involved in X-linked sub-cortical laminar heterotopia and lissencephaly syndrome. Cell1998;92:51—61.
101.
Gleeson JG , Allen KM, Fox JW, et al: Doublecortin, a brain-specific gene mutated in human X-linked lissencephaly and double cortex syndrome, encodes a putative signaling protein. Cell1998; 92:63—72.
102.
Sossey-Alaoui K., Hartung AJ, Guerrini R., et al: Human doublecortin (DCX) and the homologous gene in mouse encode a putative Ca2+-dependent signaling protein which is mutated in human X-linked neuronal migration defects. Hum Mol Genet1998;7: 1327—1332.
Eksioglu YZ , Scheffer IE, Cardenas P., et al: Periventricular heterotopia: An X-linked dominant epilepsy locus causing aberrant cerebral cortical development. Neuron1996;16:77—87.
105.
Fox JW, Lamperti ED, Eksioglu YZ, et al: Mutations in filamin 1 prevent migration of cerebral cortical neurons in human periventricular heterotopia. Neuron1998;21:1315—1325.
106.
Berkovic SF , Cochius J., Andermann E., Andermann F.: Progressive myoclonus epilepsies: Clinical and genetic aspects. Epilepsia1993;34(Suppl3):S19-S39.
107.
Norio R., Koskiniemi M.: Progressive myoclonus epilepsy: Genetic and nosological aspects with special reference to 107 Finnish patients. Clin Genet1979;15:382—398.
108.
Lehesjoki A-E., Koskiniemi M., Sistonen P., et al: Localization of a gene for progressive myoclonus epilepsy to chromosome 21q22. Proc Natl Acad Sci U S A1991;88:3696—3699.
109.
Lehesjoki A-E., Koskiniemi M., Pandolfo M., et al: Linkage studies in progressive myoclonus epilepsy: Unverricht-Lundborg and Lafora's diseases. Neurology1992;42:1545—1550.
110.
Lalioti MD , Mirotsou M., Buresi C., et al: Identification of mutations in cystatin B, the gene responsible for the Unverricht-Lundborg type of progressive myoclonus epilepsy (EPM1). Am J Hum Genet1997;60:342—351.
111.
Pennacchio LA, Lehesjoki A-E., Stone NE, et al: Mutations in the gene encoding cystatin B in progressive myoclonus epilepsy (EPM1). Science1998;271:1731—1734.
112.
Virtaneva K., D'Amato E., Miao J., et al: Unstable minisatellite expansion causing recessively inherited myoclonus epilepsy EPM1. Nat Genet1997;15:393—396.
113.
Wallace DC , Zheng XX, Lott MT, et al: Familial mitochondrial encephalomyopathy (MERRF): Genetic, pathophysiological, and biochemical characterization of a mitochondrial DNA disease. Cell1988;55:601—610.
114.
Minassian BA, Lee JR, Herbrick JA, et al: Mutations in a gene encoding a novel protein tyrosine phosphatase cause progressive myoclonus epilepsy. Nat Genet1998;20:171—174.
115.
Serratosa JM, Delgado-Escueta AV, Posada I., et al: The gene for progressive myoclonus epilepsy of the Lafora type maps to chromosome 6q . Hum Mol Genet1995;4:1657—1663.
116.
Serratosa JM, Gomez-Garre P., Gallardo ME, et al: A novel protein tyrosine phosphatase gene is mutated in progressive myoclonus epilepsy of the Lafora type (EPM2) . Hum Mol Genet1999;8:345—352.
117.
Canafoglia L., Franceschetti S., Antozzi C., et al: Epileptic phenotypes associated with mitochondrial disorders. Neurology2001;56: 1340—1346.
118.
Shoffner JM , Lott MT, Lezza AM, et al: Myoclonic epilepsy and ragged-red fiber disease (MERRF) is associated with a mitochondrial DNA tRNA (Lys) mutation . Cell1990;61:931—937.
119.
Silvestri G., Moraes CT, Shanske S., et al: A new mtDNA mutation in the tRNA (Lys) gene associated with myoclonic epilepsy and ragged-red fibers (MERRF). Am J Hum Genet1992;51:1213—1217.
120.
Montagna P. , Gallassi R., Medori R., et al: MELAS syndrome: Characteristic migrainous and epileptic features and maternal transmission. Neurology1988;38:751—754.
121.
Dimauro S. , Bonilla E., Zeviani M., et al: Mitochondrial myopathies. Ann Neurol1985;17:521—538.
122.
Kanai Y., Smith CP, Hediger MA: The elusive transporters with a high affinity for glutamate. Trends Neurosci1993;16:365—370.
123.
Rothstein JD, Dykes-Hoberg M., Pardo CA, et al: Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron1996;16: 675—686.
124.
Tanaka K., Watase K., Manabe T., et al: Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1. Science1997;276:1699—1702.
125.
Peghini P., Janzen J., Stoffel W.: Glutamate transporter EAAC-1-deficient mice develop dicarboxylic aminoaciduria and behavioral abnormalities but no neurodegeneration. EMBO J1997;16: 3822—3832.
126.
Miller HP, Levey AI, Rothstein JD, et al: Alterations in glutamate transporter protein levels in kindling-induced epilepsy. J Neurochem1997;68:1564—1570.
127.
Simantov R., Crispino M., Hoe W., et al: Changes in expression of neuronal and glial glutamate transporters in rat hippocampus following kainate-induced seizure activity. Mol Brain Res1999;65: 112—123.
128.
Eccles CU, Dykes-Hoberg M., Rothstein JD: Inhibition of synthesis of EAAC-1 glutamate transporter alters gamma-aminobutyric acid levels in discrete brain regions, abstract. Soc Neurosci1996; 22:1570.
129.
Kanai Y.: Family of neural and acidic amino acid transporters: Molecular biology, physiology and medical implications. Curr Opin Cell Biol1997;9:565—572.
130.
Ueda Y., Doi T., Tokumaru J., et al: Collapse of extracellular glutamate regulation during epileptogenesis: Down-regulation and functional failure of glutamate transporter function in rats with chronic seizures induced by kainic acid. Exp Brain Res2001;135: 199—203.
131.
Ueda Y., Willmore LJ: Sequential changes in glutamate transporter protein levels during Fe3+-induced epileptogenesis. Epilepsy Res2000;39:201—219.
132.
Guastella J., Nelson N., Nelson H., et al: Cloning and expression of a rat brain GABA transporter. Science1990;249:1303—1306.
133.
Radian R., Bendahan A., Kanner BI: Purification and identification of the functional sodium- and chloride-coupled gamma-aminobutyric acid transport glycoprotein from rat brain. J Biol Chem1986;261:15437—15441.
134.
Griffith WH , Taylor L.: Sodium valproate decreases synaptic potentiation and epileptiform activity in hippocampus. Brain Res1988;474:155—164.
135.
Gean P-W., Huang C-C., Hung C-R., Tsai J-J.: Valproic acid suppresses the synaptic response mediated by the NMDA receptors in rat amygdalar slices. Brain Res Bull1994 ;33:333—336.
136.
Zeise ML, Kasparow S., Zieglgansberger W.: Valproate suppresses N-methyl-D-aspartate-evoked, transient depolarizations in the rat neocortex in vitro. Brain Res1991 ;544:345—348.
137.
Ueda Y., Willmore LJ: Molecular regulation of glutamate and GABA transporter proteins by valproic acid in rat hippocampus during epileptogenesis. Exp Brain Res2000;133:334—339.
